Format

Send to

Choose Destination
Immunotherapy. 2013 Nov;5(11):1221-33. doi: 10.2217/imt.13.124.

An update on the use of antibodies against the filoviruses.

Author information

1
Department of Immunology & Microbial Science & The Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037, USA. erica@scripps.edu.

Abstract

Multiple recent, independent studies have confirmed that passively administered antibodies can provide effective postexposure therapy in nonhuman primates after exposure to an otherwise lethal dose of Ebola virus or Marburg virus. In this article, we review composition and performance of the antibody cocktails tested thus far, what is known about antibody epitopes on the viral glycoprotein target and ongoing research questions in further development of such cocktails for pre-exposure or emergency postexposure use.

PMID:
24188676
PMCID:
PMC4465755
DOI:
10.2217/imt.13.124
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center